Open Access
CC BY 4.0 · Brazilian Journal of Oncology 2019; 15
DOI: 10.1055/s-0044-1798259
PO IMPRESSO
TEMÁRIO: RADIOTERAPIA (SUBMISSÃO PARA O XXI CONGRESSO DA SOCIEDADE BRASILEIRA DE RADIOTERAPIA)

ESOPHAGEAL CANCER WITH METASTASIS TO THE THYROID GLAND: CASE REPORT OF A RARE EVENT

Authors

  • Nathalya Ala Yagi

    1   Hospital Araújo Jorge
  • Nilceana Maya Aires Freitas

    1   Hospital Araújo Jorge
  • Thais Renovato Gontijo

    1   Hospital Araújo Jorge
  • Mattheus Humberto do Vale

    1   Hospital Araújo Jorge
  • Sylvia Sousa Pires

    1   Hospital Araújo Jorge
  • Ana Flávia de Paula Campedelli

    1   Hospital Araújo Jorge
  • Jean Teixeira Paiva

    1   Hospital Araújo Jorge
  • Gean Silva Santos

    1   Hospital Araújo Jorge
  • Viviany Guntija Sena Aires

    1   Hospital Araújo Jorge

Case presentation: The thyroid gland is richly vascularized. However, metastasis to the thyroid is extremely rare. MJC, 70 years old, female, solid dysphagia, dyspnea, hoarseness and significant weight loss, 6 months from the date of the first consultation. Upper digestive endoscopy (UDE) examination showed ulcerated lesion 30 cm from the upper dental arch (UDA), biopsy compatible with malignant neoplasia (April/2018). On staging examinations, neck computed tomography (CT) showed the presence of a large divergent thyroid nodule. Thus, CT-associated positron emission tomography (PET-CT) was requested for diagnostic elucidation, in which there was hypercaptive focal area in the middle thoracic esophagus located below the carina level, compatible with neoplastic process (primary site) and right cervicothoracic lymph node enlargement with level IV cervical involvement, compatible with secondary neoplastic involvement. Cytology of thyroid nodule aspiration confirmed the presence of atypical squamous cells. Closed diagnosis as malignant neoplasm of medical thoracic esophagus with thyroid metastasis. Therefore, we opted for radiotherapy treatment (RT) 28x200cGy and chemotherapy (QT) with cisplatin only (August/2018 until October/2018), in a palliative character. Two months after the end of RT + QT, the patient progressed with bone and liver metastatic disease and one month after generalized metastasis, died. Discussion: The incidence of thyroid gland metastasis ranges from 1.2-24%, with 2-3% being clinically detected. The most common primary sites are breast, lung, gastrointestinal system and kidneys. Thyroid metastasis should not be confused with direct thyroid infiltration due to locally aggressive upper esophageal disease. Overall survival depends on the primary tumor site, with about 21-66 months for breast cancer and 1-12 months for lung cancer. In the described report, the patient had a 9-month survival after diagnosis of thyroid metastasis. Final comments: The case described is a rare event with a poor prognosis. Importantly, there wasn’t right thyroid infiltration due to esophageal disease. Discussion between teams is extremely important because it is a complex scenario. Hence, decisions must be individualized, taking into account the characteristics of the primary tumor, the amount of metastasis and comorbidities.



Publikationsverlauf

Artikel online veröffentlicht:
23. Oktober 2019

© 2019. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution 4.0 International License, permitting copying and reproduction so long as the original work is given appropriate credit (https://creativecommons.org/licenses/by/4.0/)

Thieme Revinter Publicações Ltda.
Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil

Bibliographical Record
Nathalya Ala Yagi, Nilceana Maya Aires Freitas, Thais Renovato Gontijo, Mattheus Humberto do Vale, Sylvia Sousa Pires, Ana Flávia de Paula Campedelli, Jean Teixeira Paiva, Gean Silva Santos, Viviany Guntija Sena Aires. ESOPHAGEAL CANCER WITH METASTASIS TO THE THYROID GLAND: CASE REPORT OF A RARE EVENT. Brazilian Journal of Oncology 2019; 15.
DOI: 10.1055/s-0044-1798259